Search All UT System Experts

Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients

J. Shiao, K. M. Thomas, A. S. Rahimi, R. Rao, Jingsheng Yan, Xian Jin Xie, M. DaSilva, A. Spangler, M. Leitch, R. Wooldridge, A. Rivers, D. Farr, B. Haley, D. W Nathan Kim

Research output: Contribution to journal › Article › peer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences